Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Leukemia|May 1, 1992
Amplification and sequencing of genomic breakpoints located within the M-bcr region by Vectorette-mediated polymerase chain reactionK I Mills, A M Sproul, D Ogilvie, et al.Fitoterapia|September 7, 2001
Cinchonicine-derived alkaloids from the bark of the Peruvian Ladenbergia oblongifoliaA L Okunade, W H Lewis, M P Elvin-Lewis, et al.Nucleic Acids Research|July 11, 1990
Isolation of cDNA clones using yeast artificial chromosome probesP Elvin, G Slynn, D Black, et al.British Journal of Cancer|January 1, 1990
A sequence previously identified as metastasis-related encodes an acidic ribosomal phosphoprotein, P2M G Sharp, S M Adams, P Elvin, et al.British Journal of Cancer|January 1, 1997
Plasminogen activator inhibitor type 2 in breast cancerC Duggan, S Kennedy, M D Kramer, et al.Journal of Ethnopharmacology|May 1, 1991
Ritualistic use of the holly Ilex guayusa by Amazonian Jívaro IndiansW H Lewis, E J Kennelly, G N Bass, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1996
Vascular endothelial growth factor stimulates protein kinase C-dependent phospholipase D activity in endothelial cellsL W Seymour, M A Shoaibi, A Martin, et al.Enzyme & Protein|January 1, 1996
Urokinase plasminogen activator as a predictor of aggressive disease in breast cancerM J Duffy, C Duggan, T Maguire, et al.Genomics|January 1, 1992
Walking, cloning, and mapping with yeast artificial chromosomes: a contig encompassing D21S13 and D21S16R Butler, D J Ogilvie, P Elvin, et al.Breast Cancer Research and Treatment|April 15, 2008
Src inhibitors in early breast cancer: a methodology, feasibility and variability studyR J Jones, O Young, L Renshaw, et al.Pageof 3